Medicine,
Journal Year:
2024,
Volume and Issue:
103(11), P. e37349 - e37349
Published: March 15, 2024
The
coronavirus
disease
2019
(COVID-19)
outbreak
caused
by
SARS-CoV-2
(severe
acute
respiratory
syndrome
coronavirus-2)
has
affected
various
medical
fields
worldwide.
However,
relatively
few
studies
have
examined
the
impact
of
COVID-19
infection
and
vaccination
on
in
vitro
fertilization
(IVF)
outcomes
changes
antibody
concentration
follicular
fluid
(FF).
A
total
45
women
were
prospectively
recruited
assigned
to
3
groups:
uninfected
non-vaccinated
control
group
(Control
group),
infected
(COVID
+
vaccinated
(Vaccination
group).
Serum
(FF)
estradiol,
progesterone,
concentrations
measured.
There
no
statistical
differences
number
retrieved
oocytes
(P
=
.291),
mature
.416),
good-quality
embryos
.694)
among
groups.
In
group,
BNT162b2
exhibited
a
significantly
lower
trigger-day
serum
estradiol/MII
oocyte
level
(110.6
pg/mL)
than
other
vaccines
(289.5
.006).
No
.687)
FF
.108)
noted
Only
statistically
significant
between
vaccine
subgroups
.047).
do
not
affect
IVF
outcomes.
effect
steroidogenesis
SARS-CoV2
titer
should
be
further
investigated.
Journal of Korean Medical Science,
Journal Year:
2023,
Volume and Issue:
38(27)
Published: Jan. 1, 2023
Paxlovid
is
an
oral
antiviral
drug
that
received
emergency
use
authorization
in
South
Korea
for
the
treatment
of
patients
with
mild-to-moderate
coronavirus
disease
2019
(COVID-19)
on
January
14,
2022.
Since
onset
severe
acute
respiratory
syndrome
2
pandemic,
virus
has
continued
to
evolve.
The
emergence
new
variants
raised
concerns
about
possible
reductions
effectiveness
vaccines
and
drugs.
infected
omicron
variant
subvariants
not
yet
been
determined.
This
study
assessed
at
reducing
risk
severe/critical
illness
or
death
COVID-19
caused
by
subvariant
BA.5.In
this
nationwide
retrospective
cohort
study,
data
8,902,726
were
collected
from
four
sources
(the
Drug
Utilization
Review
database,
Patient
Information
Management
System,
confirmed
patient
information,
basic
epidemiological
investigation
data)
between
July
1
November
30,
Multivariable
logistic
regression
analysis
was
conducted,
adjustment
age,
sex,
immunity
(vaccination),
comorbidities.A
total
1,936,925
included
analysis,
including
420,996
treated
Paxlovid,
1,515,959
Paxlovid.
aged
≥
60
years
age
associated
significantly
reduced
(46.0%),
rate
(32.5%),
its
high,
regardless
vaccination
status.Paxlovid
effective
due
BA.5
infection,
especially
older
patients,
status.
suggests
COVID-19-related
symptoms
should
be
administered
their
status,
reduce
severity
death.
Journal of Korean Medical Science,
Journal Year:
2023,
Volume and Issue:
38(44)
Published: Jan. 1, 2023
Social
isolation
and
control
owing
to
coronavirus
disease
2019
(COVID-19)
are
easing;
however,
concerns
regarding
new
infectious
diseases
have
not
disappeared.
Given
epidemic
experiences
such
as
severe
acute
respiratory
syndrome
(SARS),
the
influenza
pandemic,
Middle
East
(MERS),
COVID-19,
it
is
necessary
prepare
for
outbreak
of
situations
in
which
large-scale
vaccinations
required.
Although
development
vaccines
against
COVID-19
has
contributed
greatly
overcoming
concerning
vaccine
side
effects
from
general
public,
including
medical
personnel,
decreased
confidence
efficacy
effects,
present
many
challenges
promoting
educating
future.
In
addition
plans
develop
diseases,
education
promotion
administer
latest
developments
public.
Moreover,
efforts
needed
secure
necessity,
legitimacy,
evidence
rapid
vaccination
on
a
large
scale
at
national
level.
It
also
carefully
scientific
bases
explanatory
statements
so
that
public
can
easily
understand
them.
This
study
aimed
establish
strategies
may
occur
Many
ways
promote
healthcare
workers
should
be
prepared
ensure
administered
safely.
Thus,
safety
based
specific
data
clinical
studies
necessary.
Infection and Chemotherapy,
Journal Year:
2024,
Volume and Issue:
56(1), P. 25 - 25
Published: Jan. 1, 2024
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
Omicron
variant
(B.1.1.529)
is
dominating
disease
2019
(COVID-19)
worldwide.
waning
protective
effect
of
available
vaccines
against
the
a
critical
public
health
issue.
This
study
aimed
to
assess
impact
third
COVID-19
vaccination
on
immunity
SARS-CoV-2
BA.1
strain
in
older
individuals.
Journal of Korean Medical Science,
Journal Year:
2024,
Volume and Issue:
39(5)
Published: Jan. 1, 2024
In
Korea,
there
are
no
surveillance
programs
for
vaccines
that
not
included
in
the
national
immunization
program
(NIP),
and
vaccine
safety
monitoring
adult
population
is
inadequate.
This
study
aimed
to
establish
a
system
non-NIP
adults.
Journal of Korean Medical Science,
Journal Year:
2024,
Volume and Issue:
39(6)
Published: Jan. 1, 2024
Coronavirus
disease
2019
(COVID-19)
vaccination
is
effective
in
preventing
the
transmission
and
progression.
However,
relatively
mild
course
of
omicron
variant
decrease
antibodies
over
time
after
raise
questions
about
effectiveness
vaccination,
especially
young
people.
We
compared
prevalence
pneumonia
chest
X-ray
severity
score
according
to
status
among
patients
<
50
years
old
with
COVID-19.
BMC Public Health,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: March 4, 2024
Abstract
Introduction
Vaccine
hesitancy
is
an
ongoing
problem
and
determining
the
factors
that
increase
vaccination
rate
in
various
countries
of
world
might
be
useful
for
further
implementation
efficient
public
health
policies
negating
anti-vaccination
campaigns.
Materials
methods
Human
Development
Index
(HDI),
Education
(EI),
Democracy
(DI),
COVID-19
rates,
data
were
collected
from
sources
such
as
UNDP
-
Reports,
UNESCO
Index,
Economist
Intelligence,
WHO–
Dashboard,
Our
World
In
Data,
The
Financial
Times
Dashboard.
Statistical
analysis
Pearson
correlation,
linear
regression
analyses
done
to
determine
a
relation
between
above-mentioned
indices
rates
(1-dose,
2-dose,
booster,
combined).
Results
HDI
had
strongest
positive
correlation
with
(1-dose–
r
(181)
=
0.632,
p
<
0.001,
2-dose–
0.671,
booster–
0.718,
combined–
0.703,
0.001).
EI
(177)
0.560,
0.599,
0.642,
0.626,
0.001),
DI
(163)
0.445,
0.479,
0.534,
0.508,
well
Geographic
location
η
(Eta)
0.610
0.633
0.657,
0.645,
0.001)
rates.
Conclusion
There
strong
EI.
PLoS ONE,
Journal Year:
2024,
Volume and Issue:
19(10), P. e0312309 - e0312309
Published: Oct. 22, 2024
The
COVID-19
pandemic
highlighted
the
critical
importance
of
vaccination
in
controlling
infectious
diseases.
While
previous
research
has
identified
social
cohesion
as
a
potential
facilitator
health
behaviors,
empirical
studies
exploring
its
direct
impact
on
rates,
especially
across
different
age
groups,
remain
limited.
This
cross-sectional
study
utilized
data
from
2021
Korean
Community
Health
Survey,
nationally
representative
survey
conducted
South
Korea.
analysis
focused
adults
aged
50
and
older,
categorizing
them
into
two
groups
(50–64
≥65).
We
investigated
association
between
perceived
neighborhood
status,
for
socio-economic
concerns
related
to
COVID-19.
Statistical
was
using
complex
sample
multiple
logistic
regression
adjust
confounders.
included
135,352
participants,
with
an
showing
that
group
≥65,
higher
levels
were
significantly
associated
increased
uptake
(aOR
trust
neighbors:
1.200,
95%
CI:
1.058–1.362;
aOR
mutual
assistance
among
1.491,
1.312–1.695).
Interestingly,
these
associations
not
significant
50–64
group.
Additionally,
satisfaction
healthcare
services
both
(aOR:
1.106,
1.004–1.219
50–64;
aOR:
1.306,
1.160–1.471
Our
findings
suggest
plays
crucial
role
influencing
older
adults,
particularly
those
65
above.
These
results
indicate
policies
aimed
at
enhancing
may
effectively
improve
elderly.
Future
should
explore
other
assess
causal
relationships
longitudinal
studies.